No Health Care Reform? No Problem For Wholesalers
Executive Summary
A strong quarter by the three major drug wholesalers shows the industry is in strong shape with or without health care reform, AmerisourceBergen CEO David Yost said
You may also be interested in...
ABC Sees Double Opportunity For Wholesalers In Biosimilars
AmerisourceBergen is anticipating that the establishment of an FDA approval pathway for biosimilars under health care reform will have a real upside for drug wholesalers
ABC Sees Double Opportunity For Wholesalers In Biosimilars
AmerisourceBergen is anticipating that the establishment of an FDA approval pathway for biosimilars under health care reform will have a real upside for drug wholesalers
Eloxatin's Wild Ride: Generics Back On The Market After Five-Day Stay Of Approval
Sanofi-Aventis loses its suit against FDA as appeals court backs agency in ruling filed under seal.